-2%
Atropine prevents or delay the progression of myopia in young children (4-14 years)
Myatro Atropine Sulphate 0.01% Ophthalmic Solution 5ml belongs to a group of medicines known as mydriatics and cycloplegics. It is utilized in the treatment of uveitis or iritis (inflammation in the eye) and myopia (near-sightedness). Additionally, it is indicated for cycloplegia (paralysis of the ciliary eye muscle), mydriasis (pupil dilation), and the penalization of the healthy eye in the treatment of amblyopia (reduced eyesight due to abnormal vision development). Furthermore, it is employed before specific eye examinations to widen the pupil and diagnose eye problems, such as blurred vision in children below 6 years and children with convergent strabismus (cross-eyes or squint).
- Use Myatro Atropine Sulphate 0.01% Ophthalmic Solution 5mll as prescribed by your doctor, based on your medical condition.
- Common side effects may include dry mouth, palpitations, nausea, constipation, and vomiting. Most side effects are temporary and do not require medical attention. Consult your doctor if they persist.
- Consult a doctor before use if pregnant or breastfeeding.
- Myatro Atropine Sulphate 0.01% Ophthalmic Solution 5ml may cause blurred vision; avoid driving or operating machinery until vision is clear.
- Avoid touching the dropper’s tip to prevent contamination. Wash hands after use.
- Keep your doctor informed about your health condition and medications to avoid potential side effects or interactions.
